Search research articles
Contact Us
Filters
Showing results (231-240 of 271) with videos related to
Page
of 28
Sort By:
Cancer Research
|
February 5, 2003
A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins
J Blake Marriott, Ian A Clarke, Anna Czajka, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 3, 2006
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis
Mahmoud Kiaei, Susanne Petri, Khatuna Kipiani, et al.
Nature Medicine
|
November 1, 1995
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia
M Grossman, D J Rader, D W Muller, et al.
Journal of Reproductive Immunology
|
January 9, 1998
Histological studies of gene-ablated mice support important functional roles for natural killer cells in the uterus during pregnancy
B A Croy, A A Ashkar, R A Foster, et al.
British Journal of Cancer
|
March 5, 2004
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers
J B Bartlett, A Michael, I A Clarke, et al.
Bioorganic & Medicinal Chemistry
|
September 30, 2011
1,1-Diarylalkenes as anticancer agents: dual inhibitors of tubulin polymerization and phosphodiesterase 4
Alexander L Ruchelman, Hon-Wah Man, Roger Chen, et al.
Journal of the American College of Cardiology
|
December 1, 1991
Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction. TAMI-5 Study Group
D W Muller, E J Topol, S G Ellis, et al.
Journal of the American College of Cardiology
|
September 14, 1999
Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data set
M Moscucci, G T O'Connor, S G Ellis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study
C J A Punt, H J Keizer, J Douma, et al.
Cancer Research
|
September 10, 2009
Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism
Laure Escoubet-Lozach, I-Lin Lin, Kristen Jensen-Pergakes, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 271) with videos related to
Sort By:
Page
of 28
Cancer Research
|
February 5, 2003
A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins
J Blake Marriott, Ian A Clarke, Anna Czajka, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 3, 2006
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis
Mahmoud Kiaei, Susanne Petri, Khatuna Kipiani, et al.
Nature Medicine
|
November 1, 1995
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia
M Grossman, D J Rader, D W Muller, et al.
Journal of Reproductive Immunology
|
January 9, 1998
Histological studies of gene-ablated mice support important functional roles for natural killer cells in the uterus during pregnancy
B A Croy, A A Ashkar, R A Foster, et al.
British Journal of Cancer
|
March 5, 2004
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers
J B Bartlett, A Michael, I A Clarke, et al.
Bioorganic & Medicinal Chemistry
|
September 30, 2011
1,1-Diarylalkenes as anticancer agents: dual inhibitors of tubulin polymerization and phosphodiesterase 4
Alexander L Ruchelman, Hon-Wah Man, Roger Chen, et al.
Journal of the American College of Cardiology
|
December 1, 1991
Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction. TAMI-5 Study Group
D W Muller, E J Topol, S G Ellis, et al.
Journal of the American College of Cardiology
|
September 14, 1999
Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data set
M Moscucci, G T O'Connor, S G Ellis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study
C J A Punt, H J Keizer, J Douma, et al.
Cancer Research
|
September 10, 2009
Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism
Laure Escoubet-Lozach, I-Lin Lin, Kristen Jensen-Pergakes, et al.
Page
of 28